We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · December 09, 2020

Tezepelumab in Patients With Severe, Uncontrolled Asthma

Annals of Allergy, Asthma & Immunology


Additional Info

Disclosure statements are available on the authors' profiles:

Annals of Allergy, Asthma & Immunology
Tezepelumab Improves Patient-Reported Outcomes in Patients With Severe, Uncontrolled Asthma in PATHWAY
Ann. Allergy Asthma Immunol. 2020 Oct 23;[EPub Ahead of Print], J Corren, E Garcia Gil, JM Griffiths, JR Parnes, R van der Merwe, K Sałapa, S O'Quinn

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading